Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cyclic β2,3-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease
Takashi Miura, Tika R. Malla, Lennart Brewitz, et al.
Bulletin of the Chemical Society of Japan (2024) Vol. 97, Iss. 5
Open Access | Times Cited: 11

Showing 11 citing articles:

Localized assembly in biological activity: Origin of life and future of nanoarchitectonics
Jingwen Song, Kohsaku Kawakami, Katsuhiko Ariga
Advances in Colloid and Interface Science (2025) Vol. 339, pp. 103420-103420
Closed Access | Times Cited: 3
Layer-by-Layer Nanoarchitectonics: A Method for Everything in Layered Structures
Katsuhiko Ariga
Materials (2025) Vol. 18, Iss. 3, pp. 654-654
Open Access | Times Cited: 3
Expanding the genetic code: In vivo approaches for incorporating non-proteinogenic monomers
Dongheon Lee, S Yun, Jong‐il Choi
The Journal of Microbiology (2025) Vol. 63, Iss. 3, pp. e2501005-e2501005
Closed Access | Times Cited: 1
Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies
Dóra Laczi, Sofia Schönbauer Huamán, Taylah Andrews-Clark, et al.
European Journal of Medicinal Chemistry (2025), pp. 117603-117603
Open Access
A phycobiliprotein-based reporter assay for the evaluation of SARS-CoV-2 main protease activity
Le Cao, Shuyuan Shi, Chaofeng Zhang, et al.
Virology (2025) Vol. 608, pp. 110540-110540
Closed Access
Design, Synthesis, and Anti-SARS-CoV-2 Activity of Amodiaquine Analogs
Shin Aoki, Tomohiro Tanaka, Kenta Yokoi, et al.
Chemical and Pharmaceutical Bulletin (2025) Vol. 73, Iss. 4, pp. 355-368
Open Access
Thiophene-fused γ-lactams inhibit the SARS-CoV-2 main protease via reversible covalent acylation
Gayatri Tehlan, Lennart Brewitz, Lewis T. Ibbotson, et al.
Chemical Science (2024) Vol. 15, Iss. 20, pp. 7667-7678
Open Access | Times Cited: 3
Nanoarchitectonics of Polymers at Interfaces
Katsuhiko Ariga
Macromolecular Chemistry and Physics (2025)
Open Access
In Vitro Selection of Macrocyclic l-α/d-α/β/γ-Hybrid Peptides Targeting IFN-γ/IFNGR1 Protein–Protein Interaction
Takashi Miura, KangJu Lee, Takayuki Katoh, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 26, pp. 17691-17699
Closed Access | Times Cited: 2
De Novo Discovery of a Noncovalent Cell-Penetrating Bicyclic Peptide Inhibitor Targeting SARS-CoV-2 Main Protease
Yahong Tan, Jinyue Yang, Min Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20258-20274
Closed Access | Times Cited: 1
Synthesis of extended fluorinated tripeptides based on the tetrahydropyridazine scaffold
Thierry Milcent, Pascal Retailleau, Benoı̂t Crousse, et al.
Beilstein Journal of Organic Chemistry (2024) Vol. 20, pp. 3174-3181
Open Access
Page 1

Scroll to top